Medical Filtration Market - Global Forecast To 2030
商品番号 : SMB-73331
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年2月 |
| ページ数 | 354 |
| 図表数 | 425 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The medical filtration market is projected to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024, at a CAGR of 6.8%.
医療用濾過市場は、CAGR 6.8%で、2024年の62億9,000万米ドルから2030年までに93億5,000万米ドルに達すると予測されています
The urgent demand for quality filtration solutions serves as a major driving force for this market, especially with healthcare providers and research institutions prioritizing patient safety along with effective products. Advanced filtration technologies that ensure the removal of contaminants have therefore become paramount. This trend is majorly influenced by stringent regulatory standards and rising importance of maintaining sterile environments in medical settings.
高品質のろ過ソリューションに対する緊急の需要が、特に効果的な製品とともに患者の安全を優先する医療提供者や研究機関にとって、この市場の大きな原動力となっています。したがって、汚染物質を確実に除去する高度なろ過技術が最も重要になっています。この傾向は、厳格な規制基準と、医療現場での無菌環境を維持する重要性の高まりによって主に影響を受けています。
There is also growing demand for reliable filtration systems to support clinical and diagnostics applications, supported by the increase in chronic diseases in laboratories. Hence, the companies have ample opportunities to innovate and develop specialized filtration products catering to such evolving needs and enhancing their market presence and driving future growth.
また、研究室における慢性疾患の増加に支えられ、臨床および診断用途をサポートする信頼性の高い濾過システムに対する需要も高まっています。したがって、企業には、そのような進化するニーズに応え、市場での存在感を高め、将来の成長を促進する特殊な濾過製品を革新および開発する十分な機会があります。
“Based on material, PVDF is the second fastest growing material in medical filtration market during the forecast period, in terms of value.”
PVDF is the second-fastest-growing material in the medical filtration market due to its exceptional chemical resistance, high thermal stability, and excellent mechanical properties. These properties make it very suitable for demanding medical applications like sterile filtration and membrane-based devices. Compatibility with a wide range of sterilization techniques such as autoclaving and gamma radiation makes PVDF highly useful in medical filtration. Its hydrophobic nature and resistance to aggressive cleaning agents also make it increasingly popular. As healthcare and bioprocessing technologies advance, the demand for strong and efficient filtration materials grow increasing the adoption of PVDF .
“Based on end-use industry, hospitals account the largest share in medical filtration market during the forecast period, in terms of value.”
The largest market share of the medical filtration market is captured by hospitals due to their role in infection prevention and patient safety. In fact, rising hospital admissions on account of surging chronic diseases, surgical procedures, and the aging population is boosting the demand for advanced filtration systems. Hospitals rely heavily on filtration solutions in terms of sterile air and water for medical devices including ventilators, IV infusion systems, and surgical tools. Growth in infection control in hospitals coupled with the necessity to meet severe regulatory standards leads to further growth in adoption. Moreover, developing healthcare infrastructure in many emerging economies contributes to hospitals’ being the top end-use industry.
“Based on region, North America accounts the largest share and Asia pacific is the fastest growing region in medical filtration market, in terms of value.”
North America accounts the largest share in medical filtration market majorly because of its developed healthcare infrastructure, strict regulatory standards, and high expenditure on healthcare services. This is further fueled by significant presence of major medical filtration manufacturing companies in the region with high demands for advanced filtration solutions. Increased prevalence of chronic diseases along with an aging population has created a need for more filtration systems within hospitals, laboratories, and in home care. Infection control, as also seen within the North America, has further added to the use of advanced filtration technologies following COVID-19. Asia Pacific is a rapidly growing market for medical filtration, supported by rapid urbanization, expansive healthcare infrastructure growth, and the increasing investments being made in medical industries. Its large and aging population, with improved awareness of healthcare hygiene, encourages the consumption of medical filtration products. China and India are significant emerging economies since the governments and medical tourism drive the country to grow more rapidly.
In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: Directors- 35%, Managers – 25%, and Others – 40%
- By Region: North America – 22%, Europe – 22%, Asia Pacific – 45%, RoW – 11%
The key players in this market are Merck KGaA (Germany), 3M (Solventum) (US), Danaher (US), Sartorius AG (Germany), Veolia (France), Thermo Fisher Scientific Inc (US), Donaldson Company Inc (US), Baxter (US), Parker Hannifin Corp (US), Entegris (US), Asahi Kasei Corporation (Japan), and Mann+Hummel (Germany).
Research Coverage
This report segments the medical filtration market based on material, process technology, design/process, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical filtration market.
Key benefits of buying this report
This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical filtration market, high-growth regions, and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing demand for high quality filtration solutions, Regulatory and quality standards and Growing focus on infection control), restraints (High cost of advanced filtration systems), opportunities (Growing healthcare investment in emerging economies and Advancements in filtration technologies) and challenges (Disposal of filters and Product performance variability).
- Market Penetration: Comprehensive information on the medical filtration market offered by top players in the global medical filtration market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical filtration market.
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for medical filtration market across regions.
- Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical filtration market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical filtration market
Table of Contents
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 STUDY SCOPE 33
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 33
1.3.2 INCLUSIONS & EXCLUSIONS 34
1.3.3 YEARS CONSIDERED 34
1.3.4 CURRENCY CONSIDERED 34
1.3.5 UNITS CONSIDERED 34
1.4 STAKEHOLDERS 35
1.5 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.1.1 SECONDARY DATA 37
2.1.1.1 List of key secondary sources 37
2.1.1.2 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Key data from primary sources 38
2.1.2.2 List of key primary interview participants 39
2.1.2.3 Key industry insights 39
2.1.2.4 Breakdown of interviews with experts 39
2.2 MARKET SIZE ESTIMATION 40
2.2.1 BOTTOM-UP APPROACH 40
2.2.2 TOP-DOWN APPROACH 41
2.3 GROWTH FORECAST 42
2.4 DATA TRIANGULATION 43
2.5 FACTOR ANALYSIS 44
2.6 RESEARCH ASSUMPTIONS 44
2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL FILTRATION MARKET 50
4.2 MEDICAL FILTRATION MARKET, BY MATERIAL 50
4.3 MEDICAL FILTRATION MARKET, BY APPLICATION 51
4.4 MEDICAL FILTRATION MARKET, BY END USER 51
4.5 MEDICAL FILTRATION MARKET, BY KEY COUNTRY 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing demand for advanced healthcare solutions 54
5.2.1.2 Rising awareness of infection control 56
5.2.1.3 Technological advancements 56
5.2.2 RESTRAINTS 56
5.2.2.1 High capital investments 56
5.2.2.2 Stringent regulatory compliance 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growing healthcare investments in emerging economies 57
5.2.3.2 Adoption of single-use technologies 57
5.2.4 CHALLENGES 58
5.2.4.1 Speed and yield issues 58
5.3 PORTER’S FIVE FORCES ANALYSIS 59
5.3.1 THREAT OF NEW ENTRANTS 59
5.3.2 THREAT OF SUBSTITUTES 60
5.3.3 BARGAINING POWER OF SUPPLIERS 60
5.3.4 BARGAINING POWER OF BUYERS 60
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 61
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 61
5.4.2 QUALITY 62
5.4.3 SERVICE 62
5.5 MACROECONOMIC OUTLOOK 63
5.5.1 GDP TRENDS AND FORECASTS 63
5.6 IMPACT OF AI/GEN AI 66
5.7 VALUE CHAIN ANALYSIS 67
5.7.1 RAW MATERIAL SUPPLIERS 67
5.7.2 MANUFACTURERS 67
5.7.3 DISTRIBUTORS 67
5.7.4 END USERS 68
5.8 ECOSYSTEM ANALYSIS 68
5.9 CASE STUDY ANALYSIS 69
5.9.1 VALIDATING PEGASUS PRIME VIRUS REMOVAL FILTERS WITH PREFILTERS 69
5.9.2 ENHANCING DIALYSIS FILTRATION EFFICIENCY – FRESENIUS MEDICAL CARE 70
5.9.3 BLOOD FILTRATION FOR SEPSIS TREATMENT – CYTOSORBENTS CORPORATION 71
5.10 TARIFF AND REGULATORY LANDSCAPE 71
5.10.1 ENVIRONMENTAL REGULATIONS 71
5.10.2 NORTH AMERICA 71
5.10.3 ASIA PACIFIC 72
5.10.4 EUROPE 72
5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
5.11 TECHNOLOGY ANALYSIS 75
5.11.1 KEY TECHNOLOGIES 75
5.11.1.1 Microfiltration 75
5.11.1.2 Ultrafiltration 75
5.11.1.3 Nanofiltration 75
5.11.2 COMPLEMENTARY TECHNOLOGIES 76
5.11.2.1 Single-use technology 76
5.11.3 ADJACENT TECHNOLOGIES 76
5.11.3.1 Chromatography 76
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77
5.13 TRADE ANALYSIS 78
5.13.1 EXPORT SCENARIO (HS CODE 8421) 78
5.13.2 IMPORT SCENARIO (HS CODE 8421) 79
5.14 KEY CONFERENCES AND EVENTS, 2025–2026 80
5.15 PRICING ANALYSIS 82
5.15.1 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 82
5.15.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023 83
5.15.3 AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023 83
5.16 INVESTMENT AND FUNDING SCENARIO 84
5.17 PATENT ANALYSIS 84
5.17.1 INTRODUCTION 84
5.17.2 LEGAL STATUS OF PATENTS 86
5.17.3 JURISDICTION ANALYSIS 86
6 MEDICAL FILTRATION MARKET, BY MATERIAL 87
6.1 INTRODUCTION 88
6.2 POLYSULFONE & POLYETHERSULFONE 90
6.2.1 EXCELLENT MECHANICAL STRENGTH, THERMAL STABILITY, AND CHEMICAL RESISTANCE TO BOOST MARKET 90
6.3 POLYVINYLIDENE FLUORIDE 90
6.3.1 EXCEPTIONAL CHEMICAL RESISTANCE, THERMAL STABILITY, AND MECHANICAL STRENGTH TO DRIVE MARKET 90
6.4 POLYTETRAFLUOROETHYLENE 91
6.4.1 SUPERIOR FILTRATION PERFORMANCE IN CRITICAL MEDICAL APPLICATIONS TO PROPEL DEMAND 91
6.5 POLYPROPYLENE 91
6.5.1 EXCELLENT CHEMICAL RESISTANCE, DURABILITY, AND COST-EFFECTIVENESS TO DRIVE DEMAND 91
6.6 OTHER MATERIALS 92
7 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY 93
7.1 INTRODUCTION 94
7.2 ULTRAFILTRATION 96
7.2.1 INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASE AND RISING DEMAND FOR DIALYSIS TREATMENTS TO BOOST MARKET 96
7.3 MICROFILTRATION 96
7.3.1 GROWING USAGE IN STERILIZATION, WATER PURIFICATION, AND BIOPHARMACEUTICAL MANUFACTURING TO DRIVE DEMAND 96
7.4 NANOFILTRATION 97
7.4.1 LOW ENERGY CONSUMPTION AND HIGH FILTRATION EFFICIENCY TO SUPPORT MARKET GROWTH 97
7.5 REVERSE OSMOSIS 97
7.5.1 CRUCIAL ROLE IN ENSURING SAFETY OF WATER IN MEDICAL PROCEDURES TO BOOST MARKET 97
7.6 GAS FILTRATION 98
7.6.1 DELIVERY OF HIGH-QUALITY FILTERED AIR TO FUEL GROWTH 98
7.7 OTHER PROCESS TECHNOLOGIES 98
8 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS 99
8.1 INTRODUCTION 100
8.2 SYSTEMS (RTU UNITS) 101
8.2.1 CONVENIENCE, TIME-SAVING BENEFITS, AND ABILITY TO ENSURE CONSISTENT FILTRATION PERFORMANCE TO BOOST MARKET 101
8.3 FILTRATION MODULES (CONSUMABLES) 102
8.3.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND FOR FILTRATION MODULES IN HEALTHCARE 102
8.4 OTHER DESIGNS/PROCESSES 102
9 MEDICAL FILTRATION MARKET, BY END USER 103
9.1 INTRODUCTION 104
9.2 HOSPITALS 106
9.2.1 REQUIREMENT OF HIGH-PURITY WATER FOR WOUND CARE, SURGICAL PROCEDURES, STERILIZATION, AND DIALYSIS TO DRIVE MARKET 106
9.3 DIAGNOSTIC CENTERS 106
9.3.1 DEMAND FOR HIGH-PURITY WATER, FLUIDS, AND AIR TO ENSURE RELIABLE DIAGNOSTICS TO DRIVE GROWTH 106
9.4 RESEARCH INSTITUTES 107
9.4.1 INCREASE IN BIOLOGICAL STUDIES, AND MEDICAL RESEARCH TO BOOST MARKET 107
9.5 OTHER END USERS 107
10 MEDICAL FILTRATION MARKET, BY APPLICATION 108
10.1 INTRODUCTION 109
10.2 DIALYSIS 111
10.2.1 ACCURACY AND OPERATIONAL FILTRATION EFFICIENCY IN BLOOD PURIFICATION TO BOOST GROWTH 111
10.3 DRUG DELIVERY 111
10.3.1 PROVISION OF OPTIMAL CONDITIONS THROUGH CONSISTENT FLOW RATES AND MINIMUM PRESSURE DROPS TO FUEL MARKET GROWTH 111
10.4 IV INFUSION & STERILE FILTRATION 112
10.4.1 HIGH LEVEL OF PRECISION IN CONTAMINANT REMOVAL WHILE PRESERVING FLUID INTEGRITY TO DRIVE GROWTH 112
10.5 ENDOSCOPY 112
10.5.1 ENHANCEMENT OF SAFETY AND PERFORMANCE WITH ADVANCED FILTRATION TO BOOST MARKET 112
10.6 STERILE PROCESSING 113
10.6.1 GROWING DEMAND FOR SURGICAL INSTRUMENTS, ENDOSCOPES, AND REUSABLE MEDICAL DEVICES TO PROPEL MARKET 113
10.7 BIO-ARTIFICIAL PROCESSES 113
10.7.1 VITAL ROLE OF SOPHISTICATED FILTRATION SYSTEMS IN DEVELOPMENT AND FUNCTIONALITY OF BIO-ARTIFICIAL ORGANS TO BOOST MARKET 113
10.8 OTHER APPLICATIONS 114
11 MEDICAL FILTRATION MARKET, BY REGION 115
11.1 INTRODUCTION 116
11.2 ASIA PACIFIC 118
11.2.1 CHINA 127
11.2.1.1 Strong economic growth and expanding healthcare sector to drive market 127
11.2.2 JAPAN 129
11.2.2.1 Growing aging population to propel market 129
11.2.3 INDIA 131
11.2.3.1 Increasing investments in healthcare sector to drive market 131
11.2.4 SOUTH KOREA 133
11.2.4.1 Rising demand for high-quality medical filtration solutions to drive market 133
11.2.5 REST OF ASIA PACIFIC 135
11.3 EUROPE 137
11.3.1 GERMANY 146
11.3.1.1 Economic strength, increasing healthcare expenditure, and rapidly aging population to drive market 146
11.3.2 UK 148
11.3.2.1 Rising geriatric population to support market growth 148
11.3.3 FRANCE 150
11.3.3.1 Aging population and enhancement of healthcare system to propel market 150
11.3.4 ITALY 151
11.3.4.1 Growing aging population to increase demand 151
11.3.5 SPAIN 153
11.3.5.1 Rising demand for advanced medical solutions to propel market 153
11.3.6 REST OF EUROPE 155
11.4 NORTH AMERICA 157
11.4.1 US 165
11.4.1.1 Stringent regulatory guidelines and increasing healthcare spending to boost market 165
11.4.2 CANADA 167
11.4.2.1 Growing aging population and significant government investments in healthcare infrastructure to drive market growth 167
11.4.3 MEXICO 169
11.4.3.1 Government initiatives and growth of healthcare sector to drive market 169
11.5 MIDDLE EAST & AFRICA 171
11.5.1 GCC COUNTRIES 179
11.5.1.1 Saudi Arabia 179
11.5.1.1.1 Economic growth, increasing government investments, and rising healthcare expenditures to drive market 179
11.5.1.2 Rest of GCC Countries 181
11.5.2 SOUTH AFRICA 183
11.5.2.1 Outbreaks of contagious diseases to drive demand 183
11.5.3 REST OF MIDDLE EAST & AFRICA 184
11.6 SOUTH AMERICA 186
11.6.1 BRAZIL 194
11.6.1.1 Rising healthcare investments and expanding medical infrastructure to propel growth 194
11.6.2 ARGENTINA 195
11.6.2.1 Increasing healthcare expenditure and enhancement of medical infrastructure to drive market 195
11.6.3 REST OF SOUTH AMERICA 197
12 COMPETITIVE LANDSCAPE 200
12.1 OVERVIEW 200
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 200
12.3 REVENUE ANALYSIS, 2021–2023 202
12.4 MARKET SHARE ANALYSIS, 2023 203
12.5 COMPANY VALUATION AND FINANCIAL METRICS 205
12.6 PRODUCT COMPARISON 206
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 207
12.7.1 STARS 207
12.7.2 EMERGING LEADERS 208
12.7.3 PERVASIVE PLAYERS 208
12.7.4 PARTICIPANTS 208
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 209
12.7.5.1 Region footprint 210
12.7.5.2 Material footprint 211
12.7.5.3 Process technology footprint 212
12.7.5.4 Design/Process footprint 213
12.7.5.5 Application footprint 214
12.7.5.6 End user footprint 215
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 216
12.8.1 PROGRESSIVE COMPANIES 216
12.8.2 RESPONSIVE COMPANIES 216
12.8.3 DYNAMIC COMPANIES 216
12.8.4 STARTING BLOCKS 216
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 218
12.8.5.1 Detailed list of key startups/SMEs 218
12.8.5.2 Competitive benchmarking of key startups/SMEs 219
12.9 COMPETITIVE SCENARIO 220
12.9.1 PRODUCT LAUNCHES 220
12.9.2 DEALS 221
12.9.3 EXPANSIONS 222
12.9.4 OTHER DEVELOPMENTS 223
13 COMPANY PROFILES – MEDICAL FILTRATION EQUIPMENT PROVIDERS 224
13.1 KEY PLAYERS 224
13.1.1 MERCK KGAA 224
13.1.1.1 Business overview 224
13.1.1.2 Products/Solutions/Services offered 225
13.1.1.3 Recent developments 228
13.1.1.3.1 Expansions 228
13.1.1.4 MnM view 229
13.1.1.4.1 Right to win 229
13.1.1.4.2 Strategic choices 229
13.1.1.4.3 Weaknesses and competitive threats 230
13.1.2 3M (SOLVENTUM) 231
13.1.2.1 Business overview 231
13.1.2.2 Products/Solutions/Services offered 232
13.1.2.3 Recent developments 234
13.1.2.3.1 Other developments 234
13.1.2.4 MnM view 235
13.1.2.4.1 Right to win 235
13.1.2.4.2 Strategic choices 235
13.1.2.4.3 Weaknesses and competitive threats 235
13.1.3 DANAHER 236
13.1.3.1 Business overview 236
13.1.3.2 Products/Solutions/Services offered 237
13.1.3.3 Recent developments 240
13.1.3.3.1 Deals 240
13.1.3.3.2 Other developments 241
13.1.3.4 MnM view 241
13.1.3.4.1 Right to win 241
13.1.3.4.2 Strategic choices 241
13.1.3.4.3 Weaknesses and competitive threats 242
13.1.4 SARTORIUS AG 243
13.1.4.1 Business overview 243
13.1.4.2 Products/Solutions/Services offered 244
13.1.4.3 Recent developments 247
13.1.4.3.1 Product launches 247
13.1.4.4 MnM view 247
13.1.4.4.1 Right to win 247
13.1.4.4.2 Strategic choices 247
13.1.4.4.3 Weaknesses and competitive threats 247
13.1.5 ASAHI KASEI CORPORATION 248
13.1.5.1 Business overview 248
13.1.5.2 Products/Solutions/Services offered 249
13.1.5.3 MnM view 250
13.1.5.3.1 Right to win 250
13.1.5.3.2 Strategic choices 250
13.1.5.3.3 Weaknesses and competitive threats 250
13.1.6 BAXTER 251
13.1.6.1 Business overview 251
13.1.6.2 Products/Solutions/Services offered 252
13.1.6.3 Recent developments 254
13.1.6.3.1 Deals 254
13.1.6.4 MnM view 255
13.1.6.4.1 Right to win 255
13.1.6.4.2 Strategic choices 255
13.1.6.4.3 Weaknesses and competitive threats 255
13.1.7 THERMO FISHER SCIENTIFIC INC. 256
13.1.7.1 Business overview 256
13.1.7.2 Products/Solutions/Services offered 257
13.1.7.3 MnM view 260
13.1.8 VEOLIA 261
13.1.8.1 Business overview 261
13.1.8.2 Products/Solutions/Services offered 262
13.1.8.3 Recent developments 266
13.1.8.3.1 Product launches 266
13.1.8.4 MnM view 267
13.1.8.4.1 Right to win 267
13.1.8.4.2 Strategic choices 267
13.1.8.4.3 Weaknesses and competitive threats 267
13.1.9 DONALDSON COMPANY, INC. 268
13.1.9.1 Business overview 268
13.1.9.2 Products/Solutions/Services offered 269
13.1.9.3 Recent developments 270
13.1.9.3.1 Expansions 270
13.1.9.4 MnM view 270
13.1.10 PARKER HANNIFIN CORP 271
13.1.10.1 Business overview 271
13.1.10.2 Products/Solutions/Services offered 272
13.1.10.3 MnM view 273
13.1.11 ENTEGRIS 274
13.1.11.1 Business overview 274
13.1.11.2 Products/Solutions/Services offered 275
13.1.11.3 MnM view 275
13.1.12 MANN+HUMMEL 276
13.1.12.1 Business overview 276
13.1.12.2 Products/Solutions/Services offered 277
13.1.12.3 MnM view 278
13.2 OTHER PLAYERS 279
13.2.1 CORNING INCORPORATED 279
13.2.2 CRITICAL PROCESS FILTRATION, INC. 280
13.2.3 COBETTER 281
13.2.4 GRAVER TECHNOLOGIES 282
13.2.5 ERTELALSOP 284
13.2.6 KASAG SWISS AG 285
13.2.7 FILTROX AG 286
13.2.8 MEMBRANE SOLUTIONS 287
13.2.9 COLE-PARMER INSTRUMENT COMPANY, LLC 288
13.2.10 MEISSNER FILTRATION PRODUCTS, INC. 289
13.2.11 MEDICAL FILTRATION SOLUTIONS LTD. 290
13.2.12 SEFAR AG 291
13.2.13 WALKER FILTRATION 292
13.2.14 SAINT-GOBAIN 293
14 COMPANY PROFILES – AUTOMATED ENDOSCOPE REPROCESSOR PROVIDERS 294
14.1 KEY PLAYERS 294
14.1.1 STERIS 294
14.1.1.1 Business overview 294
14.1.1.2 Products/Solutions/Services offered 295
14.1.1.3 Recent developments 297
14.1.1.3.1 Deals 297
14.1.1.4 MnM view 297
14.1.1.4.1 Right to win 297
14.1.1.4.2 Strategic choices 298
14.1.1.4.3 Weaknesses and competitive threats 298
14.1.2 FORTIVE 299
14.1.2.1 Business overview 299
14.1.2.2 Products/Solutions/Services offered 300
14.1.2.3 Recent developments 301
14.1.2.3.1 Deals 301
14.1.2.4 MnM view 301
14.1.2.4.1 Right to win 301
14.1.2.4.2 Strategic choices 302
14.1.2.4.3 Weaknesses and competitive threats 302
14.1.3 OLYMPUS CORPORATION 303
14.1.3.1 Business overview 303
14.1.3.2 Products/Solutions/Services offered 304
14.1.3.3 Recent developments 305
14.1.3.3.1 Product launches 305
14.1.3.4 MnM view 305
14.1.3.4.1 Right to win 305
14.1.3.4.2 Strategic choices 305
14.1.3.4.3 Weaknesses and competitive threats 305
14.1.4 ECOLAB 306
14.1.4.1 Business overview 306
14.1.4.2 Products/Solutions/Services offered 307
14.1.4.3 Recent developments 308
14.1.4.3.1 Product launches 308
14.1.4.4 MnM view 308
14.1.4.4.1 Right to win 308
14.1.4.4.2 Strategic choices 308
14.1.4.4.3 Weaknesses and competitive threats 309
14.1.5 GETINGE 310
14.1.5.1 Business overview 310
14.1.5.2 Products/Solutions/Services offered 311
14.1.5.3 Recent developments 312
14.1.5.3.1 Expansions 312
14.1.5.4 MnM view 312
14.1.5.4.1 Right to win 312
14.1.5.4.2 Strategic choices 312
14.1.5.4.3 Weaknesses and competitive threats 313
14.1.6 STEELCOBELIMED (METALL ZUG GROUP) 314
14.1.6.1 Business overview 314
14.1.6.2 Products/Solutions/Services offered 315
14.1.6.3 Recent developments 316
14.1.6.3.1 Deals 316
14.1.6.4 MnM view 316
14.1.7 ENDO-TECHNIK W. GRIESAT (CREO) 317
14.1.7.1 Business overview 317
14.1.7.2 Products/Solutions/Services offered 317
14.1.7.3 MnM view 318
14.1.8 WASSENBURG MEDICAL B.V. (HOYA CORPORATION) 319
14.1.8.1 Business overview 319
14.1.8.2 Products/Solutions/Services offered 319
14.1.8.3 Recent developments 320
14.1.8.3.1 Deals 320
15 COMPANY PROFILES – DIALYSIS EQUIPMENT PROVIDERS 321
15.1 KEY PLAYERS 321
15.1.1 FRESENIUS MEDICAL CARE AG 321
15.1.1.1 Business overview 321
15.1.1.2 Products/Solutions/Services offered 322
15.1.1.3 Recent developments 323
15.1.1.3.1 Product launches 323
15.1.1.3.2 Deals 324
15.1.1.4 MnM view 324
15.1.1.4.1 Right to win 324
15.1.1.4.2 Strategic choices 325
15.1.1.4.3 Weaknesses and competitive threats 325
15.1.2 BAXTER 326
15.1.2.1 Business overview 326
15.1.2.2 Products/Solutions/Services offered 327
15.1.2.3 Recent developments 328
15.1.2.3.1 Deals 328
15.1.2.4 MnM view 329
15.1.2.4.1 Right to win 329
15.1.2.4.2 Strategic choices 329
15.1.2.4.3 Weaknesses and competitive threats 329
15.1.3 DAVITA INC. 330
15.1.3.1 Business overview 330
15.1.3.2 Products/Solutions/Services offered 331
15.1.3.3 Recent developments 331
15.1.3.3.1 Deals 331
15.1.3.3.2 Expansions 332
15.1.3.4 MnM view 332
15.1.3.4.1 Right to win 332
15.1.3.4.2 Strategic choices 332
15.1.3.4.3 Weaknesses and competitive threats 332
15.1.4 NIKKISO CO., LTD. 333
15.1.4.1 Business overview 333
15.1.4.2 Products/Solutions/Services offered 334
15.1.4.3 Recent developments 335
15.1.4.3.1 Deals 335
15.1.4.4 MnM view 336
15.1.4.4.1 Right to win 336
15.1.4.4.2 Strategic choices 336
15.1.4.4.3 Weaknesses and competitive threats 336
15.1.5 B. BRAUN SE 337
15.1.5.1 Business overview 337
15.1.5.2 Products/Solutions/Services offered 338
15.1.5.3 Recent developments 339
15.1.5.3.1 Product launches 339
15.1.5.3.2 Expansions 339
15.1.5.4 MnM view 340
15.1.5.4.1 Right to win 340
15.1.5.4.2 Strategic choices 340
15.1.5.4.3 Weaknesses and competitive threats 340
15.1.6 NIPRO 341
15.1.6.1 Business overview 341
15.1.6.2 Products/Solutions/Services offered 342
15.1.6.3 Recent developments 343
15.1.6.3.1 Product launches 343
15.1.7 TORAY MEDICAL CO., LTD. 344
15.1.7.1 Business overview 344
15.1.7.2 Products/Solutions/Services offered 345
15.1.8 MEDIONICS 346
15.1.8.1 Business overview 346
15.1.8.2 Products/Solutions/Services offered 346
16 APPENDIX 347
16.1 DISCUSSION GUIDE 347
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 350
16.3 CUSTOMIZATION OPTIONS 352
16.4 RELATED REPORTS 352
16.5 AUTHOR DETAILS 353
LIST OF TABLES
TABLE 1 CAPITAL HEALTHCARE EXPENDITURE, 2020–2023 (USD MILLION) 54
TABLE 2 HEALTHCARE SPENDING, 2023 (USD MILLION) 55
TABLE 3 MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 61
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 61
TABLE 5 KEY BUYING CRITERIA FOR TOP THREE END USERS 62
TABLE 6 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF
KEY COUNTRIES, 2019–2023 63
TABLE 7 ANNUAL GDP PERCENTAGE CHANGE AND PROJECTIONS FOR
KEY COUNTRIES, 2024–2029 64
TABLE 8 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019–2022 65
TABLE 9 MEDICAL FILTRATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM 69
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 13 EXPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 78
TABLE 14 IMPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 79
TABLE 15 MEDICAL FILTRATION MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 80
TABLE 16 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 88
TABLE 17 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 89
TABLE 18 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 89
TABLE 19 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION) 89
TABLE 20 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 94
TABLE 21 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 95
TABLE 22 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2021–2023 (USD MILLION) 95
TABLE 23 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2024–2030 (USD MILLION) 95
TABLE 24 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 100
TABLE 25 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 101
TABLE 26 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 101
TABLE 27 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 101
TABLE 28 MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 104
TABLE 29 MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 105
TABLE 30 MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION) 105
TABLE 31 MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION) 105
TABLE 32 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 109
TABLE 33 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 110
TABLE 34 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 110
TABLE 35 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 111
TABLE 36 MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (UNIT) 117
TABLE 37 MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (UNIT) 117
TABLE 38 MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (USD MILLION) 117
TABLE 39 MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (USD MILLION) 118
TABLE 40 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 119
TABLE 41 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 120
TABLE 42 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 120
TABLE 43 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 120
TABLE 44 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 121
TABLE 45 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 121
TABLE 46 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 121
TABLE 47 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (USD MILLION) 122
TABLE 48 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2021–2023 (UNIT) 122
TABLE 49 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2024–2030 (UNIT) 122
TABLE 50 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2021–2023 (USD MILLION) 123
TABLE 51 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2024–2030 (USD MILLION) 123
TABLE 52 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (UNIT) 123
TABLE 53 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (UNIT) 124
TABLE 54 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (USD MILLION) 124
TABLE 55 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (USD MILLION) 124
TABLE 56 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 124
TABLE 57 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 125
TABLE 58 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (USD MILLION) 125
TABLE 59 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (USD MILLION) 125
TABLE 60 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 126
TABLE 61 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 126
TABLE 62 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 126
TABLE 63 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 127
TABLE 64 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 128
TABLE 65 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 128
TABLE 66 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 128
TABLE 67 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 129
TABLE 68 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 129
TABLE 69 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 130
TABLE 70 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 130
TABLE 71 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 130
TABLE 72 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 131
TABLE 73 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 132
TABLE 74 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 132
TABLE 75 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 132
TABLE 76 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 133
TABLE 77 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 134
TABLE 78 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 134
TABLE 79 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 134
TABLE 80 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 135
TABLE 81 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 136
TABLE 82 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 136
TABLE 83 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 137
TABLE 84 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 138
TABLE 85 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 139
TABLE 86 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 139
TABLE 87 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 139
TABLE 88 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 140
TABLE 89 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 140
TABLE 90 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 140
TABLE 91 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (USD MILLION) 141
TABLE 92 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2021–2023 (UNIT) 141
TABLE 93 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2024–2030 (UNIT) 141
TABLE 94 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2021–2023 (USD MILLION) 142
TABLE 95 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY,
2024–2030 (USD MILLION) 142
TABLE 96 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (UNIT) 142
TABLE 97 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (UNIT) 143
TABLE 98 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (USD MILLION) 143
TABLE 99 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (USD MILLION) 143
TABLE 100 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 143
TABLE 101 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 144
TABLE 102 EUROPE: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (USD MILLION) 144
TABLE 103 EUROPE: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (USD MILLION) 144
TABLE 104 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 145
TABLE 105 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 145
TABLE 106 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 145
TABLE 107 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 146
TABLE 108 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 147
TABLE 109 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 147
TABLE 110 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 147
TABLE 111 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 148
TABLE 112 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 148
TABLE 113 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 149
TABLE 114 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 149
TABLE 115 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 149
TABLE 116 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 150
TABLE 117 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 150
TABLE 118 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 151
TABLE 119 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 151
TABLE 120 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 152
TABLE 121 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 152
TABLE 122 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 152
TABLE 123 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 153
TABLE 124 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 153
TABLE 125 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 154
TABLE 126 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 154
TABLE 127 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 154
TABLE 128 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 155
TABLE 129 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 155
TABLE 130 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 156
TABLE 131 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 156
TABLE 132 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2021–2023 (UNIT) 158
TABLE 133 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2024–2030 (UNIT) 158
TABLE 134 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 158
TABLE 135 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 158
TABLE 136 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (UNIT) 159
TABLE 137 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (UNIT) 159
TABLE 138 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 159
TABLE 139 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (USD MILLION) 160
TABLE 140 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 160
TABLE 141 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 160
TABLE 142 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 161
TABLE 143 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 161
TABLE 144 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (UNIT) 161
TABLE 145 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (UNIT) 162
TABLE 146 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (USD MILLION) 162
TABLE 147 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (USD MILLION) 162
TABLE 148 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (UNIT) 162
TABLE 149 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (UNIT) 163
TABLE 150 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (USD MILLION) 163
TABLE 151 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (USD MILLION) 163
TABLE 152 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 164
TABLE 153 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 164
TABLE 154 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 164
TABLE 155 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 165
TABLE 156 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 166
TABLE 157 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 166
TABLE 158 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 166
TABLE 159 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 167
TABLE 160 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 168
TABLE 161 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 168
TABLE 162 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 168
TABLE 163 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 169
TABLE 164 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 169
TABLE 165 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 170
TABLE 166 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 170
TABLE 167 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 170
TABLE 168 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2021–2023 (UNIT) 171
TABLE 169 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2024–2030 (UNIT) 171
TABLE 170 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 172
TABLE 171 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 172
TABLE 172 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (UNIT) 172
TABLE 173 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (UNIT) 173
TABLE 174 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 173
TABLE 175 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (USD MILLION) 173
TABLE 176 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET,
BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 174
TABLE 177 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET,
BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 174
TABLE 178 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET,
BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 174
TABLE 179 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET,
BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 175
TABLE 181 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 175
TABLE 182 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 176
TABLE 183 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 176
TABLE 184 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (UNIT) 176
TABLE 185 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (UNIT) 176
TABLE 186 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (USD MILLION) 177
TABLE 187 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (USD MILLION) 177
TABLE 188 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 177
TABLE 189 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 178
TABLE 190 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 178
TABLE 191 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 179
TABLE 192 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 180
TABLE 193 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 180
TABLE 194 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 180
TABLE 195 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 181
TABLE 196 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 181
TABLE 197 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 182
TABLE 198 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 182
TABLE 199 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 182
TABLE 200 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 183
TABLE 201 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 183
TABLE 202 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 184
TABLE 203 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 184
TABLE 204 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 185
TABLE 205 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 185
TABLE 206 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 185
TABLE 207 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 186
TABLE 208 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 186
TABLE 209 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 187
TABLE 210 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 187
TABLE 211 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 187
TABLE 212 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (UNIT) 187
TABLE 213 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (UNIT) 188
TABLE 214 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 188
TABLE 215 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL,
2024–2030 (USD MILLION) 188
TABLE 216 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 189
TABLE 217 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 189
TABLE 218 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 189
TABLE 219 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 190
TABLE 220 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (UNIT) 190
TABLE 221 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (UNIT) 190
TABLE 222 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2021–2023 (USD MILLION) 191
TABLE 223 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS,
2024–2030 (USD MILLION) 191
TABLE 224 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (UNIT) 191
TABLE 225 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (UNIT) 191
TABLE 226 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2021–2023 (USD MILLION) 192
TABLE 227 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER,
2024–2030 (USD MILLION) 192
TABLE 228 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (UNIT) 192
TABLE 229 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (UNIT) 193
TABLE 230 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 193
TABLE 231 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 193
TABLE 232 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 194
TABLE 233 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 194
TABLE 234 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 195
TABLE 235 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 195
TABLE 236 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 196
TABLE 237 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 196
TABLE 238 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 196
TABLE 239 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 197
TABLE 240 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 197
TABLE 241 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 198
TABLE 242 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 198
TABLE 243 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 199
TABLE 244 MEDICAL FILTRATION MARKET: DEGREE OF COMPETITION 203
TABLE 245 MEDICAL FILTRATION MARKET: REGION FOOTPRINT 210
TABLE 246 MEDICAL FILTRATION MARKET: MATERIAL FOOTPRINT 211
TABLE 247 MEDICAL FILTRATION MARKET: PROCESS TECHNOLOGY FOOTPRINT 212
TABLE 248 MEDICAL FILTRATION MARKET: DESIGN/PROCESS FOOTPRINT 213
TABLE 249 MEDICAL FILTRATION MARKET: APPLICATION FOOTPRINT 214
TABLE 250 MEDICAL FILTRATION MARKET: END USER FOOTPRINT 215
TABLE 251 MEDICAL FILTRATION MARKET: KEY STARTUPS/SMES 218
TABLE 252 MEDICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 219
TABLE 253 MEDICAL FILTRATION MARKET: PRODUCT LAUNCHES,
JANUARY 2019–JANUARY 2025 220
TABLE 254 MEDICAL FILTRATION MARKET: DEALS, JANUARY 2019–JANUARY 2025 221
TABLE 255 MEDICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019–JANUARY 2025 222
TABLE 256 MEDICAL FILTRATION MARKET: OTHER DEVELOPMENTS,
JANUARY 2019–JANUARY 2025 223
TABLE 257 MERCK KGAA: COMPANY OVERVIEW 224
TABLE 258 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 225
TABLE 259 MERCK KGAA: EXPANSIONS, JANUARY 2019–JANUARY 2025 228
TABLE 260 3M (SOLVENTUM): COMPANY OVERVIEW 231
TABLE 261 3M (SOLVENTUM): PRODUCTS/SOLUTIONS/SERVICES OFFERED 232
TABLE 262 3M (SOLVENTUM): OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2025 234
TABLE 263 DANAHER: COMPANY OVERVIEW 236
TABLE 264 DANAHER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 237
TABLE 265 DANAHER: DEALS, JANUARY 2019–JANUARY 2025 240
TABLE 266 DANAHER: OTHERS, JANUARY 2019–JANUARY 2025 241
TABLE 267 SARTORIUS AG: COMPANY OVERVIEW 243
TABLE 268 SARTORIUS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244
TABLE 269 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 247
TABLE 270 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 248
TABLE 271 ASAHI KASEI CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 249
TABLE 272 BAXTER: COMPANY OVERVIEW 251
TABLE 273 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 274 BAXTER: DEALS, JANUARY 2019–JANUARY 2025 254
TABLE 275 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 256
TABLE 276 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257
TABLE 277 VEOLIA: COMPANY OVERVIEW 261
TABLE 278 VEOLIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 262
TABLE 279 VEOLIA: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 266
TABLE 280 DONALDSON COMPANY, INC.: COMPANY OVERVIEW 268
TABLE 281 DONALDSON COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269
TABLE 282 DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025 270
TABLE 283 PARKER HANNIFIN CORP: COMPANY OVERVIEW 271
TABLE 284 PARKER HANNIFIN CORP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 272
TABLE 285 ENTEGRIS: COMPANY OVERVIEW 274
TABLE 286 ENTEGRIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
TABLE 287 MANN+HUMMEL: COMPANY OVERVIEW 276
TABLE 288 MANN+HUMMEL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 277
TABLE 289 CORNING INCORPORATED: COMPANY OVERVIEW 279
TABLE 290 CRITICAL PROCESS FILTRATION, INC.: COMPANY OVERVIEW 280
TABLE 291 COBETTER: COMPANY OVERVIEW 281
TABLE 292 GRAVER TECHNOLOGIES: COMPANY OVERVIEW 282
TABLE 293 ERTELALSOP: COMPANY OVERVIEW 284
TABLE 294 KASAG SWISS AG: COMPANY OVERVIEW 285
TABLE 295 FILTROX AG: COMPANY OVERVIEW 286
TABLE 296 MEMBRANE SOLUTIONS: COMPANY OVERVIEW 287
TABLE 297 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW 288
TABLE 298 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 289
TABLE 299 MEDICAL FILTRATION SOLUTIONS LTD.: COMPANY OVERVIEW 290
TABLE 300 SEFAR AG: COMPANY OVERVIEW 291
TABLE 301 WALKER FILTRATION: COMPANY OVERVIEW 292
TABLE 302 SAINT-GOBAIN: COMPANY OVERVIEW 293
TABLE 303 STERIS: COMPANY OVERVIEW 294
TABLE 304 STERIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 295
TABLE 305 STERIS: DEALS, JANUARY 2019–JANUARY 2025 297
TABLE 306 FORTIVE: COMPANY OVERVIEW 299
TABLE 307 FORTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 300
TABLE 308 FORTIVE: DEALS, JANUARY 2019–JANUARY 2025 301
TABLE 309 OLYMPUS CORPORATION: COMPANY OVERVIEW 303
TABLE 310 OLYMPUS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 304
TABLE 311 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 305
TABLE 312 ECOLAB: COMPANY OVERVIEW 306
TABLE 313 ECOLAB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 307
TABLE 314 ECOLAB: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 308
TABLE 315 GETINGE: COMPANY OVERVIEW 310
TABLE 316 GETINGE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 311
TABLE 317 GETINGE: EXPANSIONS, JANUARY 2019–JANUARY 2025 312
TABLE 318 STEELCOBELIMED (METALL ZUG GROUP): COMPANY OVERVIEW 314
TABLE 319 STEELCOBELIMED (METALL ZUG GROUP): PRODUCTS/SOLUTIONS/
SERVICES OFFERED 315
TABLE 320 STEELCOBELIMED (METALL ZUG GROUP): DEALS, JANUARY 2019–JANUARY 2025 316
TABLE 321 ENDO-TECHNIK W. GRIESAT (CREO): COMPANY OVERVIEW 317
TABLE 322 ENDO-TECHNIK W. GRIESAT (CREO): PRODUCTS/SOLUTIONS/SERVICES OFFERED 317
TABLE 323 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): COMPANY OVERVIEW 319
TABLE 324 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): PRODUCTS/SOLUTIONS/SERVICES OFFERED 319
TABLE 325 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): DEALS,
JANUARY 2019–JANUARY 2025 320
TABLE 326 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW 321
TABLE 327 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 322
TABLE 328 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES,
JANUARY 2019–JANUARY 2025 323
TABLE 329 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2019–JANUARY 2025 324
TABLE 330 BAXTER: COMPANY OVERVIEW 326
TABLE 331 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 327
TABLE 332 BAXTER: DEALS, JANUARY 2019–JANUARY 2025 328
TABLE 333 DAVITA INC.: COMPANY OVERVIEW 330
TABLE 334 DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 331
TABLE 335 DAVITA INC.: DEALS, JANUARY 2019–JANUARY 2025 331
TABLE 336 DAVITA INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025 332
TABLE 337 NIKKISO CO., LTD.: COMPANY OVERVIEW 333
TABLE 338 NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 334
TABLE 339 NIKKISO CO., LTD.: DEALS, JANUARY 2019–JANUARY 2025 335
TABLE 340 B. BRAUN SE: COMPANY OVERVIEW 337
TABLE 341 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 338
TABLE 342 B. BRAUN SE: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 339
TABLE 343 B. BRAUN SE: EXPANSIONS, JANUARY 2019–JANUARY 2025 339
TABLE 344 NIPRO: COMPANY OVERVIEW 341
TABLE 345 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 342
TABLE 346 NIPRO: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 343
TABLE 347 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW 344
TABLE 348 TORAY MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 345
TABLE 349 MEDIONICS: COMPANY OVERVIEW 346
TABLE 350 MEDIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 346
LIST OF FIGURES
FIGURE 1 MEDICAL FILTRATION MARKET AND REGIONAL SCOPE 33
FIGURE 2 MEDICAL FILTRATION MARKET: RESEARCH DESIGN 36
FIGURE 3 MEDICAL FILTRATION MARKET: BOTTOM-UP APPROACH 40
FIGURE 4 MEDICAL FILTRATION MARKET: TOP-DOWN APPROACH 41
FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL FILTRATION MARKET (TOP-DOWN APPROACH) 41
FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS 42
FIGURE 7 MEDICAL FILTRATION MARKET: DATA TRIANGULATION 43
FIGURE 8 POLYSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 47
FIGURE 9 DIALYSIS APPLICATION TO LEAD MARKET DURING FORECAST PERIOD 47
FIGURE 10 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 48
FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 49
FIGURE 12 GROWING FOCUS ON INFECTION CONTROL IN HEALTHCARE SECTOR TO DRIVE MARKET 50
FIGURE 13 POLYSULFONE & POLYETHERSULFONE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 50
FIGURE 14 IV INFUSION & STERILE FILTRATION SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51
FIGURE 15 HOSPITALS TO BE LARGEST END USER SEGMENT DURING FORECAST PERIOD 51
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 52
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL FILTRATION MARKET 53
FIGURE 18 MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 59
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 61
FIGURE 20 KEY BUYING CRITERIA FOR TOP THREE END USERS 62
FIGURE 21 MEDICAL FILTRATION MARKET: VALUE CHAIN ANALYSIS 67
FIGURE 22 MEDICAL FILTRATION MARKET: ECOSYSTEM 68
FIGURE 23 MEDICAL FILTRATION MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77
FIGURE 24 EXPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY,
2019–2023 (USD THOUSAND) 78
FIGURE 25 IMPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY,
2019–2023 (USD THOUSAND) 79
FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 (USD/UNIT) 82
FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023 (USD/UNIT) 83
FIGURE 28 AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023 (USD/UNIT) 83
FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2020–2024 (USD MILLION) 84
FIGURE 30 PATENTS APPLIED AND GRANTED, 2014–2024 85
FIGURE 31 LEGAL STATUS OF PATENTS, 2014–2024 86
FIGURE 32 TOP JURISDICTIONS 86
FIGURE 33 POLYETHERSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 88
FIGURE 34 MICROFILTRATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 94
FIGURE 35 FILTRATION MODULES (CONSUMABLES) SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 100
FIGURE 36 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 104
FIGURE 37 DIALYSIS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 109
FIGURE 38 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 116
FIGURE 39 ASIA PACIFIC: MEDICAL FILTRATION MARKET SNAPSHOT 119
FIGURE 40 EUROPE: MEDICAL FILTRATION MARKET SNAPSHOT 138
FIGURE 41 NORTH AMERICA: MEDICAL FILTRATION MARKET SNAPSHOT 157
FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL FILTRATION MARKET BETWEEN 2019 AND 2024 201
FIGURE 43 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MEDICAL FILTRATION MARKET, 2021–2023 202
FIGURE 44 MARKET SHARE OF KEY COMPANIES IN MEDICAL FILTRATION MARKET, 2023 203
FIGURE 45 VALUATION OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023 205
FIGURE 46 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL
FILTRATION MARKET, 2023 206
FIGURE 47 MEDICAL FILTRATION MARKET: PRODUCT COMPARISON ANALYSIS 206
FIGURE 48 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023 208
FIGURE 49 MEDICAL FILTRATION MARKET: OVERALL COMPANY FOOTPRINT 209
FIGURE 50 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023 217
FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT 225
FIGURE 52 3M (SOLVENTUM): COMPANY SNAPSHOT 232
FIGURE 53 DANAHER: COMPANY SNAPSHOT 237
FIGURE 54 SARTORIUS AG: COMPANY SNAPSHOT 244
FIGURE 55 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT 249
FIGURE 56 BAXTER: COMPANY SNAPSHOT 252
FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 257
FIGURE 58 VEOLIA: COMPANY SNAPSHOT 262
FIGURE 59 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT 269
FIGURE 60 PARKER HANNIFIN CORP: COMPANY SNAPSHOT 272
FIGURE 61 ENTEGRIS: COMPANY SNAPSHOT 275
FIGURE 62 MANN+HUMMEL: COMPANY SNAPSHOT 277
FIGURE 63 STERIS: COMPANY SNAPSHOT 295
FIGURE 64 FORTIVE: COMPANY SNAPSHOT 300
FIGURE 65 OLYMPUS CORPORATION: COMPANY SNAPSHOT 304
FIGURE 66 ECOLAB: COMPANY SNAPSHOT 307
FIGURE 67 GETINGE: COMPANY SNAPSHOT 311
FIGURE 68 STEELCOBELIMED (METALL ZUG GROUP): COMPANY SNAPSHOT 315
FIGURE 69 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT 322
FIGURE 70 BAXTER: COMPANY SNAPSHOT 327
FIGURE 71 DAVITA INC.: COMPANY SNAPSHOT 330
FIGURE 72 NIKKISO CO., LTD.: COMPANY SNAPSHOT 334
FIGURE 73 B. BRAUN SE: COMPANY SNAPSHOT 338
FIGURE 74 NIPRO: COMPANY SNAPSHOT 342
FIGURE 75 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT 345
。
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。
最新調査レポート
- 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
- スマートメーター市場 – 2030年までの世界予測 2025-03-07
- 産業用計測市場 – 2030年までの世界予測 2025-03-06
- 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
- グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06